Atrial Fibrillation and Stroke: Concepts and Controversies

Hart, Robert G., Halperin, Jonathan L.·2001·Stroke

Cited by (320)

Items 101–200 of 320

  1. Non-ion channel blockers as anti-arrhythmic drugs (reversal of structural remodeling)
    ANDREAS GOETTE, Alicja Bukowska, Uwe Lendeckel · 2007 · Current Opinion in Pharmacology
  2. Left atrial appendage ligation with the next generation LARIAT+ suture delivery device: Early clinical experience
    Krzysztof Bartuś, Sameer A. Gafoor, David R. Tschopp, John P. Foran, Roland Richard Tilz, Tom Wong, Dhanunjaya Lakkireddy, Horst Sievert, Randall J. Lee · 2016 · International Journal of Cardiology
  3. Thrombosis and Aging: Fibrin Clot Properties and Oxidative Stress
    Małgorzata Konieczyńska, Joanna Natorska, Anetta Undas · 2023 · Antioxidants and Redox Signaling
  4. Toward Patient-Specific Prediction of Ablation Strategies for Atrial Fibrillation Using Deep Learning
    M. Muffoletto, A. Qureshi, A. Zeidan, Laila Muizniece, Xiao Fu, Jichao Zhao, Aditi Roy, P. Bates, O. Aslanidi · 2021 · Frontiers in Physiology
  5. Surface Atrial Frequency Analysis in Patients with Atrial Fibrillation: Assessing the Effects of Linear Left Atrial Ablation
    Daniel Raine, Philip Langley, Alan Murray, STEPHEN S. FURNISS, John P. Bourke · 2005 · Journal of Cardiovascular Electrophysiology
  6. Is Atrial Fibrillation Always a Culprit of Stroke in Patients with Atrial Fibrillation plus Stroke?
    Suk Jae Kim, Sookyung Ryoo, Soonwook Kwon, Yun Kyung Park, Jun Pyo Kim, Ga Yeon Lee, Oh Young Bang · 2013 · Cerebrovascular Diseases
  7. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study
    Georgios K. Tsivgoulis · 2004 · Age and Ageing
  8. Association between Paroxysmal Atrial Fibrillation and the Left Atrial Appendage Ejection Fraction during Sinus Rhythm in the Acute Stage of Stroke: A Transesophageal Echocardiographic Study
    Takahiro Shimizu, Tatsuro Takada, Atsuko Shimode, Yuichi Fujita, Noriko Usuki, Bunta Kato, Satoshi Takaishi, Toshikazu Hirayama, Kazuhiko Hanzawa, Yasuhiro Hasegawa · 2013 · Journal of Stroke and Cerebrovascular Diseases
  9. WNT signaling in atrial fibrillation
    Carmen Wolke, Elmer Antileo, Uwe Lendeckel · 2021 · Experimental Biology and Medicine
  10. Discovery of ((S)-5-(Methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone As a Potent and Selective IKur Inhibitor
    Heather J. Finlay, John Lloyd, Wayne D. Vaccaro, Alexander Kover, Lin Yan, Gauri Bhave, J. JUN. PROL, Tram Huynh, Rao Bhandaru, Yolanda Caringal et al. · 2012 · Journal of Medicinal Chemistry
  11. An Automatic System for Real-Time Identifying Atrial Fibrillation by Using a Lightweight Convolutional Neural Network
    Dakun Lai, Xinshu Zhang, Yuxiang Bu, Ye Su, Changsheng Ma · 2019 · IEEE Access
  12. Spotlight on atrial fibrillation—the 'complete arrhythmia'
    Stanley Nattel · 2002 · Cardiovascular Research
  13. Geographic Variation in the Use of Oral Anticoagulation Therapy in Stroke Prevention in Atrial Fibrillation
    Inmaculada Hernandez, Samir Saba, Yuting Zhang · 2017 · Stroke
  14. The Multiple Causes of Stroke in Atrial Fibrillation: Thinking Broadly
    Atlantic D’Souza, Kenneth Butcher, Brian H Buck · 2018 · Canadian Journal of Cardiology
  15. A simple score to predict atherosclerotic or embolic intracranial large-vessel occlusion stroke before endovascular treatment
    Geng Liao, Zhenyu Zhang, Tao-Hsin Tung, Yuemei He, Linhui Hu, Xiong Zhang, Hai Chen, Jinbo Huang, Weijie Du, Chaomao Li et al. · 2022 · Journal of neurosurgery
  16. Four-factor Prothrombin Complex Concentrate for the Management of Patients Receiving Direct Oral Activated Factor X Inhibitors
    Oliver Grottke, Sam Schulman · 2019 · Anesthesiology
  17. Bovine Arch and Stroke Laterality
    Jason D Matakas, Menachem M. Gold, Jonathan Sterman, Linda Broyde Haramati, Michael T. Allen, Daniel Labovitz, Shira E. Slasky · 2020 · Journal of the American Heart Association
  18. Platelet Activation in Patients With Chronic Nonvalvular Atrial Fibrillation
    Hon‐Kan Yip, Li‐Teh Chang, Cheuk‐Kwan Sun, Cheng‐Hsu Yang, Wei‐Chin Hung, Chi‐Ling Hang, Chiung‐Jen Wu, Sarah O. Chua, Kuo‐Ho Yeh, Hsueh‐Wen Chang · 2006 · International Heart Journal
  19. Characterization of Cerebrovascular Events After Left Atrial Appendage Occlusion
    Xavier Freixa, Laura Llull, Sameer A. Gafoor, Ignacio Cruz‐González, Samera Shakir, Heyder Omran, Sérgio Luis Berti, Gennaro Santoro, Joëlle Kefer, Ulf Landmesser et al. · 2016 · The American Journal of Cardiology
  20. Stroke risk reduction after LAA occlusion in elderly patients with atrial fibrillation: long-term results
    Radosław Adam Litwinowicz, Magdalena Bartuś, Piotr Ceranowicz, Bogusław Kapelak, Dhanunjaya Lakkireddy, Krzysztof Bartuś · 2018 · Polskie Archiwum Medycyny Wewnętrznej
  21. Comparing Patient and Physician Risk Tolerance for Bleeding Events Associated with Anticoagulants in Atrial Fibrillation—evidence from the United States and Japan
    Ken Okumura, Hiroshi Inoue, Masahiro Yasaka, Juan Marcos González, Brett Hauber, Bennett S. Levitan, Žhong Yuan, J Brière · 2015 · Value in Health Regional Issues
  22. The current role of anticoagulants in cardiovascular medicine
    Raffaele De Caterina · 2009 · Journal of Cardiovascular Medicine
  23. Part I: Use of Echocardiography in the Evaluation of Patients with Suspected Cardioembolic Stroke
    Stamatios Lerakis, William J. Nicholson, George A. Stouffer, Daniel John Lenihan, Samatios Lerakis, Richard G. Sheahan · 2005 · The American Journal of the Medical Sciences
  24. The role of echocardiography in the management of atrial fibrillation
    R. Wheeler, Navroz D. Masani · 2011 · European Journal of Echocardiography
  25. Recomendaciones para el tratamiento y prevención del ictus, 2004
    María Alonso de Leciñana, Germán Enrique Pérez R., Exuperio Díez‐Tejedor, Oscar Benavente, Manuel Carvajal Lozano, Franz Chaves Sell, José Antonio Egido, Blanca Fuentes, José Miguel Laínez Andrés, Marco Tulio Medina et al. · 2004 · Revista de Neurología
  26. Exploring interpretability in deep learning prediction of successful ablation therapy for atrial fibrillation
    Shaheim Ogbomo-Harmitt, Marica Muffoletto, Aya Mutaz Zeidan, Ahmed Qureshi, Andrew Peter King, Oleg V. Aslanidi · 2023 · Frontiers in Physiology
  27. Is there a link between atrial fibrillation and certain bacterial infections?
    Peter Andrew, ANNIBALE SANDRO MONTENERO · 2007 · Journal of Cardiovascular Medicine
  28. ACC/AHA/ESC: Guías de Práctica Clínica 2006 para el manejo de pacientes con fibrilación auricular. Versión resumida
    Informe del Grupo de Trabajo para la elaboración de guías de práctica clínica del American College of Cardiology y de la American Heart Association, del Comité de Guías de Práctica Clínica de la Sociedad Europea de Cardiología (comité de redacción para la revisión de la Guía de práctica clínica sobre el manejo de pacientes con fibrilación auricular, 2001), Desarrollado en colaboración con las asociaciones European Heart Rhythm Association y Heart Rhythm Society · 2006 · Revista Española de Cardiología
  29. Levels of von Willebrand factor and ADAMTS13 determine clinical outcome after cardioversion for atrial fibrillation
    Veronika Bruno, Rudolf Járai, Susanne C. Gruber, Thomas Höchtl, Ivan Brozovic, Serdar Farhan, Johann Wojta, Kurt Huber, Matthias Karl Freynhofer · 2010 · Thrombosis and Haemostasis
  30. Anticoagulation Therapy and NOACs in Heart Failure
    Isac C. Thomas, Jorge EncisoSilva, Michelle Schlueter, Barry Greenberg · 2016 · Handbook of experimental pharmacology
  31. Swazi Concepts of intelligence: The Universal versus the Local
    Margaret Zoller Booth · 2002 · Ethos
  32. AUtomated Risk Assessment for Stroke in Atrial Fibrillation (AURAS-AF) - an automated software system to promote anticoagulation and reduce stroke risk: study protocol for a cluster randomised controlled trial
    Tim Holt, David Andrew Fitzmaurice, Tom P Marshall, Matthew Fay, Nadeem Qureshi, Andrew RH Dalton, Richard F. Hobbs, Daniel S Lasserson, Karen E Kearley, Jenny Hislop et al. · 2013 · Trials
  33. Effects of Aging on the Coagulation Fibrinolytic System in Outpatients of the Cardiovascular Department
    Akinori Ochi, Taro Adachi, Koichiro Inokuchi, Ko Ogawa, Yuya Nakamura, Yuta Chiba, Shiro Kawasaki, Yoshimi Onishi, Yoshimasa Onuma, Yumi Munetsugu et al. · 2016 · Circulation Journal
  34. Outcome, Recurrence and Mortality after Non-Valvular Atrial Fibrillation Stroke: Long-Term Follow-Up Study.
    Antonio Araúz, Francisco Ruiz-Navarro, Miguel Angel Barboza, Angélica Ruíz, Jonathan Colín, Marisela Reyes, Humberto Silos, Carlos Gerardo Cantú-Brito, Luis Manuel Murillo-Bonilla, Fernando Barinagarrementería · 2017 · PubMed Central
  35. Secondary Prevention of Stroke
    Hans‐Christian Koennecke · 2004 · CNS Drugs
  36. Comparison of transesophageal echocardiographic identification of embolic risk markers in patients with lone versus non–lone atrial fibrillation
    Emanuele Di Angelantonio, Stéphane Éderhy, Nadia Benyounes, Sandra Janower, Franck Boccara, Ariel A. Cohen · 2005 · The American Journal of Cardiology
  37. Multimodal Sensing in Stroke Motor Rehabilitation
    Zihe Zhao, Jiaqi Wang, Shengbo Wang, Rui Wang, Yao Lu, Yan Yuan, Junliang Chen, Yanning Dai, Yong Liu, Xiaomeng Wang et al. · 2023 · Advanced Sensor Research
  38. Triflusal: An Antiplatelet Drug with a Neuroprotective Effect?
    José Antonio González Correa, José Pedro De La Cruz · 2006 · Cardiovascular Drug Reviews
  39. Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation
    George Iype Varughese, Jeetesh V. Patel, Joseph Tomson, Gregory Y.H. Lip · 2006 · Heart
  40. A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of??Hypertension with Left Ventricular Hypertrophy
    Aslam Hayat Anis, Huiying Sun, Sonia Singh, John C. Woolcott, Bohdan Nosyk, Marc Brisson · 2006 · PharmacoEconomics
  41. Time Course of Platelet Activation and von Willebrand Factor in Patients With Non-Valvular Atrial Fibrillation After Ischemic Stroke Evaluation of Prognostic Determinants
    Hon‐Kan Yip, Shung-Lon Lai, Min‐Yu Lan, Wen‐Neng Chang, Josef S. Liu, Yi-Fen Kao, Yung‐Yee Chang, Cheng‐Hsien Lu, Wei-Hsi Chen, Lin Hung-Hseng et al. · 2007 · Circulation Journal
  42. CYP11B2 T-344C Gene Polymorphism and Atrial Fibrillation: A Meta-Analysis of 2,758 Subjects
    Yanyan Li, Chuanwei Zhou, Jian Xu, Yun Qian, Bei Wang · 2012 · PLoS ONE
  43. New strategies in the surgical treatment of atrial fibrillation
    Haw Sie · 2003 · Cardiovascular Research
  44. Impaired transport function of the left atrium and left atrial appendage in cryptogenic stroke patients with atrial septal aneurysm and without patent foramen ovale
    Jin Oh Na, Seung Yong Shin, Hong Euy Lim, Cheol Ung Choi, Sung Hoon Kim, Jae‐Hoon Kim, Eung Ju Kim, E. M. Lee, Seung‐Woon Rha, Chang Gyu Park et al. · 2010 · European Journal of Echocardiography
  45. Blood Pressure Control and the Reduction of Left Atrial Overload is Essential for Controlling Atrial Fibrillation
    Yasuko Tanabe, Yuichiro Kawamura, Naka Sakamoto, Nobuyuki Sato, Kenjiro Kikuchi, Naoyuki Hasebe · 2009 · International Heart Journal
  46. Pyrano-[2,3b]-pyridines as potassium channel antagonists
    Heather J. Finlay, John Lloyd, Michael C. Nyman, Mary Lee Conder, Tonya West, Paul Lévesque, Karnail S. Atwal · 2008 · Bioorganic & Medicinal Chemistry Letters
  47. Atrial Fibrillation
    Stanley Nattel, Joachim R. Ehrlich · 2004 · Elsevier eBooks
  48. Editorial Comment—Routine Thrombophilia Testing in Stroke Patients Is Unjustified
    Graeme J. Hankey, John W. Eikelboom · 2003 · Stroke
  49. Angiotensin-converting enzyme insertion/deletion gene polymorphisms associated with risk of atrial fibrillation: A meta-analysis of 23 case-control studies
    Runwei Ma, Xiang Li, Guoning Su, Yunfei Hong, WU Xing-jian, Ji‐Yang Wang, Ziliang Zhao, Yi Song, Shaohong Ma · 2015 · Journal of the Renin-Angiotensin-Aldosterone System
  50. Manejo de los pacientes con fibrilación auricular en los servicios de urgencias hospitalarios (actualización 2012)
    Alfonso Martı́n, Ignacio Fernández Lozano, Blanca Coll-Vinent Puig, Luís Tercedor, Carmen del Arco, Fernando Arribas Ynsaurriaga, Coral Suero Méndez, Lluís Mont Girbau · 2012 · Emergencias
  51. Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A systematic review and meta‐analysis
    Jianfu Zhu, Xiao‐Wei Tan, Jian Zhou · 2021 · Clinical Cardiology
  52. Vernakalant: A novel agent for the termination of atrial fibrillation
    Miki Finnin · 2010 · American Journal of Health-System Pharmacy
  53. Diagnosis and Management of Atrial Fibrillation by Primary Care Physicians in Italy
    Gaetano Piccinocchi, Matteo Laringe, Bruno Guillaro, Giovanni Arpino, Roberto Piccinocchi, Gerardo Nigro, Paolo Calabrò · 2012 · Clinical Drug Investigation
  54. Increased Left Ventricular Filling Pressure and Arterial Occlusion in Stroke Related to Atrial Fibrillation
    Wi‐Sun Ryu, Eun‐Kee Bae, Soo-Hyun Park, Sang‐Wuk Jeong, Dawid Schellingerhout, Matthias Nahrendorf, Dong‐Eog Kim · 2018 · Journal of Stroke and Cerebrovascular Diseases
  55. Comparing the Cost Effectiveness of Non-vitamin K Antagonist Oral Anticoagulants with Well-Managed Warfarin for Stroke Prevention in Atrial Fibrillation Patients at High Risk of Bleeding
    Alexa R. Hospodar, Kenneth J. Smith, Yuting Zhang, Inmaculada Hernandez · 2018 · American Journal of Cardiovascular Drugs
  56. Simvastatin reduces platelet–endocardium adhesion in atrial fibrillation
    Massimo Chello, Cristiano Spadaccio, Giuseppe Patti, Mario Lusini, Raffaele Barbato, Costanza Goffredo, Germano Di Sciascio, Elvio Covino · 2007 · Atherosclerosis
  57. Nonembolic, hemodynamic blood flow disturbances in the middle cerebral arteries in patients with paroxysmal atrial fibrillation without significant carotid stenosis
    Agata Porębska, Przemysław Nowacki, Krzysztof Safranow, Hanna Drechsler · 2007 · Clinical Neurology and Neurosurgery
  58. L’âge, un facteur indépendant de risque de thrombose
    Isabelle Mahé, C Caulin, Jean‐François Bergmann · 2005 · La Presse Médicale
  59. Cardioembolic Strokes in Eastern Iran and the Importance of Rheumatic Valvular Disease
    Kavian Ghandehari · 2006 · DergiPark (Istanbul University)
  60. Transcatheter left atrial appendage exclusion, gold or fool's gold?
    Ahmed Aziz Khattab, Bernhard Meier · 2010 · European Heart Journal Supplements
  61. Machine Learning Identifies Six Genetic Variants and Alterations in the Heart Atrial Appendage as Key Contributors to PD Risk Predictivity
    Daniel Ho, William S. Schierding, Sophie L. Farrow, Antony A. Cooper, Andreas W. Kempa-Liehr, Justin Martin O'Sullivan · 2022 · Frontiers in Genetics
  62. Paroxysmal Atrial Fibrillation in Cryptogenic Stroke: an Overlooked Explanation?
    Cen Zhang, Scott Eric Kasner · 2015 · Current Atherosclerosis Reports
  63. Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists
    Heather J. Finlay, Ji Jiang, Yolanda Caringal, Alexander Kover, Mary Lee Conder, Dezhi Xing, Paul Lévesque, Timothy M. Harper, Mei-Mann Hsueh, Karnail S. Atwal et al. · 2013 · Bioorganic & Medicinal Chemistry Letters
  64. Is Helicobacter pylori a Cause of Atrial fibrillation?
    Peter Andrew, ANNIBALE SANDRO MONTENERO · 2006 · Future Cardiology
  65. Malabarase, a serine protease with anticoagulant activity from Trimeresurus malabaricus venom
    R. Venkatesh Kumar, M. Yariswamy, Vikram Joshi, Kattepura Krishnappa Dharmappa, Shivaprasad H. Venkatesha, B.K. Sharath, Bannikuppe Sannanaik Vishwanath · 2012 · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology
  66. Changes in Cardiac Thrombus Status after Cerebral Ischemia
    Souvik Sen, João A.C. Lima, Stephen M. Oppenheimer · 2003 · Cerebrovascular Diseases
  67. Newer antiarrhythmic agents for maintaining sinus rhythm in atrial fibrillation: simplicity or complexity?
    Bramah N. Singh, Etienne Aliot · 2007 · European Heart Journal Supplements
  68. Modeling aging in HIV infection in nonhuman primates to address an emerging challenge of the post-ART era
    Tianyu He, Elizabeth Falwell, Egidio Brocca‐Cofano, Ivona Pandrea · 2017 · Current Opinion in Virology
  69. Prediction of the Multisegment Clot Sign on Dynamic CT Angiography of Cardioembolic Stroke
    Zhicai Chen, Feina Shi, Meixia Zhang, Xiaoxian Gong, Longting Lin, Min Lou · 2018 · American Journal of Neuroradiology
  70. Assessment of the manifestations of atrial fibrillation in patients with acute cerebral stroke – a single-center study based on 998 patients
    Paweł Warmus, Natalia Niedziela, Maciej Huć, Krzysztof Wierzbicki, Monika Helena Adamczyk-Sowa · 2020 · Neurological Research
  71. Differences among Clinical Classification Schemes for Predicting Stroke in Atrial Fibrillation: Implications for Therapy in Daily Practice
    Pedro Laguna, Alfonso Martı́n, Carmen del Arco, Isabel Millán, Pedro Gargantilla, On behalf of the investigators in the Spanish Atrial Fibrillation in Emergency Medicine Study Group (GEFAUR-2) · 2005 · Academic Emergency Medicine
  72. Proteomics in myocardial diseases
    Alicja Bukowska, Uwe Lendeckel, Thilo Kähne, Andreas Goette · 2004 · Pathology - Research and Practice
  73. Ablation vs. drug use for atrial fibrillation
    Pierre Jaı̈s, Douglas L. Packer · 2007 · European Heart Journal Supplements
  74. Stroke emboli from patients with atrial fibrillation enriched with neutrophil extracellular traps
    Sajal Medha K Akkipeddi, Redi Rahmani, Derrek A. Schartz, Siddharth Chittaranjan, Nathaniel R. Ellens, Gurkirat Singh Kohli, Tarun Bhalla, Thomas K Mattingly, Kevin A. Welle, Craig N. Morrell et al. · 2024 · Research and Practice in Thrombosis and Haemostasis
  75. Vernakalant: Review of a Novel Atrial Selective Antiarrhythmic Agent and its Place in Current Treatment of Atrial Fibrillation
    Kostas Bronis, Sofia Metaxa, Spyridon N. Koulouris, Antonis S. Manolis · 2012 · Hospital chronicles/Hospital Chronicles
  76. Characterization of thrombogenic, endothelial and inflammatory markers in supraventricular tachycardia: a study in patients with structurally normal hearts
    C. Schultz, Geetanjali Rangneker, Han Sung Lim, Angelique Fraudeau, Glenn D. Young, Kurt C. Roberts‐Thomson, Bobby John, Matthew Ian Worthley, Prashanthan Sanders, Scott R. Willoughby · 2014 · Clinical and Experimental Pharmacology and Physiology
  77. Cryptogenic Stroke
    Mary P. Amatangelo · 2020 · Critical Care Nursing Clinics of North America
  78. Association of stroke risk biomarkers with stroke symptoms: the Reasons for Geographic and Racial Differences in Stroke cohort
    Kara K. Landry, Kristine Alexander, Neil A. Zakai, Suzanne E. Judd, Dawn Kleindorfer, Virginia J. Howard, George Howard, Mary Cushman · 2016 · Journal of Thrombosis and Haemostasis
  79. Risk Prediction for Ischemic Stroke and Transient Ischemic Attack in Patients Without Atrial Fibrillation: A Retrospective Cohort Study
    Žhong Yuan, Erica A. Voss, Frank DeFalco, Guohua Pan, Patrick B. Ryan, Daniel Yannicelli, Christopher C. Nessel · 2017 · Journal of Stroke and Cerebrovascular Diseases
  80. Pulmonary vein ablation: role in preventing atrial fibrillation
    Chin‐Feng Tsai, Ching‐Tai Tai, Shih‐Ann Chen · 2003 · Current Opinion in Cardiology
  81. Chapter 5 Neuropathology of ischemic brain injury
    Jun Ogata, Hiromichi Yamanishi, Leonardo Pantoni · 2008 · Handbook of clinical neurology
  82. Oral Anticoagulants vs. Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Verdict is in
    Carl van Walraven, Robert G. Hart, Daniel E. Singer, Peter J. Koudstaal, Stuart J. Connolly · 2003 · Cardiac Electrophysiology Review
  83. Atrial fibrillation and cryptogenic stroke. What is the current evidence? Role of electrocardiographic monitoring
    Raimundo Carmona Puerta, Yaniel Castro Torres · 2017 · Journal of Arrhythmia
  84. A knowledge embedded multimodal pseudo-siamese model for atrial fibrillation detection
    Chenglin Lin, Huimin Lu, Pengcheng Sang, Chenyu Pan · 2025 · Scientific Reports
  85. Detection of atrial fibrillation based on Stockwell transformation using convolutional neural networks
    B. Mohan Rao, Aman Kumar, Naresh Bachwani, Puneeta Marwaha · 2023 · International Journal of Information Technology
  86. Challenges and misconceptions in the aetiology and management of atrial fibrillation-related strokes
    Vincent Thijs, Kenneth Butcher · 2015 · European Journal of Internal Medicine
  87. Dielectric permittivity change detects the process of blood coagulation: Comparative study of dielectric coagulometry with rotational thromboelastometry
    Yoichi Otaki, Yusuke Ebana, Shunji Yoshikawa, Mitsuaki Isobe · 2016 · Thrombosis Research
  88. An Assessment of Osteoporotic Conditions among Users and Non-Users of Warfarin: A Case-Control Study
    Aseel Hadi Abdulameer · 2017 · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
  89. Neue Antiarrhythmika in der Therapie des Vorhofflimmerns
    Matthias Hammwöhner, A. D’Alessandro, Dobromir Dobrev, Paulus F. Kirchhof, Andreas Goette · 2006 · Herzschrittmachertherapie + Elektrophysiologie
  90. Neue Antiarrhythmika in der Therapie des Vorhofflimmerns
    Ursula Ravens, Erich Wettwer, Ulrich Schotten, Ralf E. Wessel, Dobromir Dobrev · 2006 · Herzschrittmachertherapie + Elektrophysiologie
  91. Association between antithrombotic therapy after stroke in patients with atrial fibrillation and the risk of net clinical outcome: an observational cohort study
    Hyo‐Jeong Ahn, So‐Ryoung Lee, JungMin Choi, Kyung‐Yeon Lee, Soonil Kwon, Eue‐Keun Choi, Seil Oh, Gregory Y.H. Lip · 2024 · EP Europace
  92. The Strengths and Weaknesses of Left Atrial Appendage Ligation or Exclusion (LARIAT, AtriaClip, Surgical Suture)
    Randall J. Lee, Thorsten Hanke · 2022 · Interventional Cardiology Clinics
  93. Atrial fibrillation in pigs induces left atrial endocardial transcriptional remodelling
    Jorge Cerveró, Víctor Segura, Alfonso Macı́as, Juán José Gavira, Ramón Montes, José Hermida · 2012 · Thrombosis and Haemostasis
  94. Ibutilide – recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation
    Sheila Anne Doggrell, Jules C. Hancox · 2005 · Expert Opinion on Investigational Drugs
  95. Differences in Brain Natriuretic Peptide Value between Transient Ischemic Attack and Stroke Patients with Atrial Fibrillation
    Kensaku Shibazaki, Kazumi Kimura, Yasuyuki Iguchi, Junya Aoki, Kenichiro Sakai, Kazuto Kobayashi · 2011 · European Neurology
  96. Prevalence and risk factors of atrial fibrillation in preterminal inpatients aged 60 years and over
    Jiefu Yang, Bing Liu, Dongge Liu, Yao Luo, Fang FANG · 2008 · Chinese Medical Journal
  97. Clinical characteristics of complex aortic plaque in patients with non-valvular atrial fibrillation
    Pil‐Sung Yang, Tae‐Hoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Boyoung Joung, Moon‐Hyoung Lee, Hui‐Nam Pak · 2016 · International Journal of Cardiology
  98. Primary care provider payment models and adherence to anticoagulation in patients with atrial fibrillation
    Lanting Yang, Jingchuan Serena Guo, Qingfeng Liang, Terri Victoria Newman, Walid F. Gellad, Inmaculada Hernandez · 2021 · Journal of Managed Care & Specialty Pharmacy
  99. PLXND1-mediated calcium dyshomeostasis impairs endocardial endothelial autophagy in atrial fibrillation
    Mengjia Sun, Zhen Chen, Yuanbin Song, Bo Zhang, Jie Yang, Tan H · 2022 · Frontiers in Physiology
  100. The outcome of pulmonary vein thrombosis in non-surgical patients. A systematic review and case report
    Fernando Javier Vázquez, Pilar Paulin, P. Rodríguez, Martin Lubertino, Esteban Gándara · 2015 · Thrombosis and Haemostasis